(Q36742742)

16 August 2017

1 reference

title

Monitoring gene changes during antiepileptic drug therapy to widen the safety window and reduce pharmacoresistance (English)

1 reference

16 August 2017

Tracy A Glauser

1

1 reference

16 August 2017

publication date

1 January 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

48 Suppl 1

1 reference

16 August 2017

page(s)

19-25

1 reference

Elixirs, diluents, and the passage of the 1938 Federal Food, Drug and Cosmetic Act.

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

Idiosyncratic drug reactions: a mechanistic evaluation of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

Metabolic concerns associated with antiepileptic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

Pharmacogenomics in the treatment of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

Microarrays and toxicology: the advent of toxicogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

Exploring the new world of the genome with DNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

From genomics to proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

Mass spectrometry-based proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

'The 39 steps' in gene expression profiling: critical issues and proposed best practices for microarray experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

Bodyweight gain and anticonvulsants: a comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

Weight gain with valproate or carbamazepine--a reappraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

Exploration, normalization, and summaries of high density oligonucleotide array probe level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

affy--analysis of Affymetrix GeneChip data at the probe level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

Systems biology. Life's complexity pyramid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2007.00995.X

10.1111/J.1528-1167.2007.00995.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference